|
|
|
|
|
|
|
|
|
Webinar: Engineering affordability into customizable advanced microscopy platforms
|
Join Ensorcell's Jeff DeFrank for an introduction to Cellular Focus™, a customizable microscopy platform that enables researchers to build application-specific imaging workstations without the high cost and complexity of traditional microscope customization. Learn how Ensorcell combines OEM components, software integration, and hardware reconfiguration to create purpose-built solutions for confocal, light sheet, and spinning disc imaging, and discover the platform firsthand at the company's Cambridge, MA demo facility.
|
|
|
|
|
|
|
|
By Ray Dogum, chief editor, Drug Discovery Online
|
Omni Therapeutics is developing first-in-class nucleotides from a novel immune metabolite, using Nucleate support to advance colorectal cancer programs.
|
|
|
|
|
|
Organizing Digital Systems Around Novel Modalities
|
|
By Jason Bock, Ph.D., and Duane Avant
|
Cell therapies represent an important advancement in our ability to treat difficult cancers, but continued exploration of this new modality will require new digital tools and equipment.
|
|
|
|
Botanical Therapeutics For CNS Disorders
|
|
A conversation with Joel Stanley, AJNA Biosciences
|
We caught up with Joel Stanley, founder and CEO of AJNA Biosciences, to talk about botanical drug development.
|
|
|
|
|
|
|
|
|
|
Antibody-Based Drug Discovery At The Speed Of Light
|
|
White Paper | Curia
|
Review this end-to-end workflow, including First-to-Human antibody development strategies, the use of the PentaMice® platform for targeted immunization, and the precision of single B cell screening.
|
|
|
|
|
|
Everything You Need To Know About NGS
|
|
E-Book | INTEGRA Biosciences
|
Next generation sequencing technologies and workflow automation are accelerating genomic research. Learn key differences between sequencing methods and uncover strategies to boost efficiency.
|
|
|
|
|
|
Extrahepatic Delivery Of mRNA-LNP To Spleen
|
|
Poster | By Kalyan Golla, Sams Sadat, Hossein Yazdani Ahmadabadi, et al., Cytiva
|
In vivo CAR-T approaches aim to reprogram T cells directly in the body using targeted lipid nanoparticles. Improved delivery to immune organs highlights new potential for scalable cell therapies.
|
|
|
|
|
|
|
|
|
|
|
The Advanced Therapies Congress USA is America's largest commercial cell and gene therapy conference and exhibition. The event is for the leaders of the world’s ATMP developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. Join us in Boston for 2026! Use code LSC20 for 20% off. Book your ticket now
|
|
|
|
|
|
|
|
|
|
|
